H. Lundbeck AS, founded in 1915 and headquartered in Valby, Denmark, is a global pharmaceutical company dedicated to developing innovative treatments for brain disorders. The company specializes in therapies for psychiatric and neurological conditions, with key products including antidepressants and antipsychotic medications.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| LUNDC 0.88% 2027-10-14 EURH. Lundbeck AS | Denmark | 2027-10-14 | 0.875 | 2.64 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
H. Lundbeck AS has a history of bond issuances dating back several years, with notable issuances including a €500 million bond in 2020 to refinance existing debt and support strategic growth initiatives. The company currently offers bonds with competitive yields compared to the pharmaceutical industry, reflecting strong investor confidence. Recently, they issued a green bond, aligning with sustainability goals while attracting environmentally conscious investors.